Zyprexa risks significantly increase a patient's chance of developing diabetes and other related complications. These Zyprexa risks have been known, both by the makers of this top selling drug, Eli Lilly, and the federal government, for years yet nothing has been done to adequately protect consumers from the potentially deadly side effects of Zyprexa. Zyprexa users should be aware of the Zyprexa risks including the signs and symptoms of side effects, the risk factors, and the prevalence of Zyprexa side effects.
Zyprexa is an atypical antipsychotic prescription medication. In 1996 the FDA approved Zyprexa for the treatment of schizophrenia and bipolar disorder. Some experts allege that the FDA had knowledge of Zyprexa risks from pre-marketing clinical trials, yet chose not to convey information about these risks to consumers. One report found that Zyprexa risks were so great during these clinical trials that two thirds of the trial participants were unable to complete the studies. One in 145 clinical trial participants reportedly died during the studies due, in part, to Zyprexa risks. This information was not made available to the public.
Zyprexa risks were also acknowledged by foreign governments long before Zyprexa risks received attention from the United States government. The Japanese and British governments issued statements about diabetes-related Zyprexa risks in 2002. The FDA did not officially recognize Zyprexa risks until late 2003, after a Duke University study produced undeniable evidence of serious and life-threatening Zyprexa risks.
In 2002 Duke University published a study that documented nearly three hundred cases of treatment emergent diabetes in Zyprexa patients. Of the 289 patients who suffered from these Zyprexa risks, 225 developed diabetes within the first six months of Zyprexa treatment. Of these Zyprexa victims, one hundred also developed ketoacidosis, a potentially fatal diabetes complication marked by severe insulin deficiency. More than twenty patients developed Zyprexa related pancreatitis. In the Duke study alone, twenty three people lost their lives because of the complications of severe Zyprexa risks.
In September 2003 the FDA ordered Eli Lilly to strengthen consumer warnings about Zyprexa risks. Eli Lilly complied by adding Zyprexa risks information about diabetes and related complications such as hyperglycemia, ketoacidosis, coma, and death to all patient product information. The warnings about Zyprexa risks state that all patients should be carefully monitored for any changes in glucose control. Patients with a family history of diabetes are at an increased risk of suffering from Zyprexa risks. Physical symptoms which may indicate Zyprexa side effects include weakness, and excessive thirst, hunger, and/or urination. People who use Zyprexa should seek medical attention at the first sign of any unusual symptoms that may indicate Zyprexa risks.
If you or a loved one is taking Zyprexa, and you are concerned about Zyprexa risks, you may wish to speak to an attorney who can advise you of your rights in order to seek compensation for your Zyprexa related loses. To learn more about Zyprexa risks, please contact us to speak to an experienced and highly qualified attorney in your area.
Contact us for more information on Zyprexa side effects and Zyprexa lawsuits.